VOLPI, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.922
EU - Europa 13.081
AS - Asia 4.310
SA - Sud America 205
AF - Africa 77
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 32
Totale 43.685
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.791
GB - Regno Unito 5.205
IT - Italia 2.485
SE - Svezia 1.565
CN - Cina 1.475
UA - Ucraina 938
DE - Germania 932
TR - Turchia 789
HK - Hong Kong 624
SG - Singapore 623
FI - Finlandia 473
BG - Bulgaria 385
FR - Francia 308
KR - Corea 172
IN - India 140
ES - Italia 101
VN - Vietnam 95
BR - Brasile 90
RU - Federazione Russa 89
ID - Indonesia 87
PL - Polonia 83
CH - Svizzera 81
IE - Irlanda 77
CA - Canada 70
JP - Giappone 69
IR - Iran 53
MX - Messico 52
NL - Olanda 51
AU - Australia 49
MY - Malesia 44
GR - Grecia 43
AR - Argentina 40
TH - Thailandia 40
BE - Belgio 36
RO - Romania 33
LT - Lituania 29
PE - Perù 29
CZ - Repubblica Ceca 28
RS - Serbia 28
PT - Portogallo 27
EU - Europa 25
PK - Pakistan 24
CL - Cile 20
EG - Egitto 18
PH - Filippine 17
TN - Tunisia 17
DK - Danimarca 15
DZ - Algeria 14
CO - Colombia 13
SI - Slovenia 12
MA - Marocco 11
NO - Norvegia 11
TW - Taiwan 11
ZA - Sudafrica 10
NZ - Nuova Zelanda 9
HR - Croazia 8
IL - Israele 8
EC - Ecuador 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AT - Austria 6
HU - Ungheria 6
SK - Slovacchia (Repubblica Slovacca) 6
UZ - Uzbekistan 6
AL - Albania 5
BO - Bolivia 5
MO - Macao, regione amministrativa speciale della Cina 5
SY - Repubblica araba siriana 5
CU - Cuba 4
IQ - Iraq 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
JO - Giordania 3
MK - Macedonia 3
NG - Nigeria 3
PA - Panama 3
SM - San Marino 3
UG - Uganda 3
BD - Bangladesh 2
BY - Bielorussia 2
CR - Costa Rica 2
LB - Libano 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
EE - Estonia 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
OM - Oman 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 43.685
Salva come PNG Salva come JPEG
Città #
Southend 4.419
Fairfield 3.402
Woodbridge 2.606
Chandler 2.100
Ashburn 2.087
Houston 2.048
Jacksonville 1.993
Dearborn 1.557
Seattle 1.206
Wilmington 1.188
Ann Arbor 1.185
Cambridge 1.101
Nyköping 950
Hong Kong 615
Beijing 589
Modena 429
Princeton 414
Singapore 382
Sofia 370
Izmir 365
Eugene 356
San Diego 329
New York 283
Redwood City 220
Milan 180
Helsinki 158
London 141
Des Moines 123
Rome 96
Falls Church 84
Dong Ket 80
Shanghai 73
Jakarta 65
Dublin 62
Norwalk 60
Hefei 59
Bologna 54
Boardman 51
Nanjing 50
Istanbul 46
Madrid 45
Naples 44
Kunming 40
Jinan 34
Toronto 34
Kilburn 32
Verona 31
Brussels 28
Florence 28
Seoul 28
Nanchang 27
Guangzhou 26
Turin 25
Bangkok 24
Belgrade 24
Chiswick 24
Parma 24
Hounslow 23
Fremont 22
Perugia 21
Tokyo 21
Paris 20
Dallas 19
Frankfurt am Main 19
Los Angeles 19
San Mateo 19
Auburn Hills 18
Indiana 18
Kraków 18
Mountain View 18
Philadelphia 18
Saint Petersburg 18
Chicago 17
Chongqing 17
San Francisco 17
Stockholm 17
Zhengzhou 17
Amsterdam 16
Athens 16
Buenos Aires 16
Monterrey 16
Munich 16
Ottawa 16
Prescot 16
Ankara 15
Atlanta 15
Barcelona 15
Bari 15
Caserta 15
Dongguan 15
Padova 15
San Giuliano Milanese 15
Seongnam-si 15
Torino 15
Brescia 14
Delhi 14
Jiaxing 14
Phoenix 14
Poznan 14
Bristol 13
Totale 32.815
Salva come PNG Salva come JPEG
Nome #
BIOCHIMICA STRUTTURALE, FUNZIONALE E METABOLICA 674
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 498
Two analytical approaches to the evaluation of chondroitin sulfate in european food supplements. 431
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 378
ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly 304
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 303
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 300
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 258
A 96-well assay for uronic acid carbazole reaction 230
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 227
Le arilsolfatasi come glicoconiugati: aspetti biochimico - comparati della loro regolazione 217
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 215
12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment. 215
Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs). 212
Plasmatic and urinary glycosaminoglycans characterization in mucopolysaccharidosis II Patient treated with enzyme-replacement therapy with Idursulfase 206
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 204
Isolation and structural characterization of chondroitin sulfate from bony fishes 197
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 196
Glycosaminoglycan Blotting and Detection After Electrophoresis Separation 195
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 194
Capillary blotting of glycosaminoglycans on nitrocellulose membranes after agarose-gel electrophoresis separation 194
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 184
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 184
Beta-amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. 180
Human Milk Glycosaminoglycans Inhibit in vitro the Adhesion of Escherichia coli and Salmonella fyris to Human Intestinal Cells 180
Recent advances on separation and characterization of human milk oligosaccharides. 180
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 179
Electrophoresis for the analysis of heparin purity and quality. 175
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 174
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 173
Chondroitin sulfate structure is modified in human milk produced by breast affected by invasive carcinoma. 172
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 172
I glicosaminoglicani: struttura, funzioni, tecniche analitiche di indagine, e loro modificazioni in valvole mitraliche ed aortiche di soggetti affetti da patologia degenerativa 171
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 171
Capillary electrophoresis of bacterial (lipo)polysaccharides 171
Shift of optimal pH in arylsulphatase from Mollusca depending on temperature 170
Composition and structure elucidation of human milk glycosaminoglycans 170
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 170
Adsorption of glycosaminoglycans onto coral - a new possible implant biomaterials for regeneration therapy 169
Shockwave lithotripsy and the protective role of inosine: Early and late evaluation in an experimental model 168
Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations 165
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 164
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 163
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 161
Human milk glycosaminoglycans: the state of the art and future perspectives 160
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 160
Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma 160
Comparative analysis of fatty acid profile in three eutardigrade species 160
Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry 159
High-performance capillary electrophoresis separation of hyaluronan oligosaccharides produced by Streptomyces hyalurolyticus hyaluronate lyase 157
Determination of urinary hexosamines for diagnosis of bladder pain syndrome 157
activity of chondroitin ABC lyase on dermatan sulfate partially degraded by cupric-ion-mediated free-radical treatment 156
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 156
Safety assessment of non-animal chondroitin sulfate sodium: Subchronic study in rats, genotoxicity tests and human bioavailability. 156
Different analyses measure chondroitin pharmacokinetics. 156
Separation of flavonoids and phenolic acids from propolis by capillary zone electrophoresis 155
Electrophoretic approaches to the analysis of complex polysaccharides 155
Glycosaminoglycan content in term and preterm milk during the first month of lactation 154
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 154
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses 153
Stability studies of chondroitin sulfate 153
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 151
On-line high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry profiling of human milk oligosaccharides derivatized with 2-aminoacridone 151
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 150
Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects 150
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 150
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 149
Analytical aspects of pharmaceutical grade chondroitin sulfates 149
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 149
Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE) 148
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 148
Effect of nonanimal high- and low-molecular-mass chondroitin sulfates produced by a biotechnological process in an animal model of polyarthritis 148
Effect of holder pasteurisation on human milk glycosaminoglycans 148
effects of glycosaminoglycans on u-937 leukemia-cell proliferation and differentiation - structure-function relationship 147
Oral bioavailability of chondroitin sulfate (Condrosulf (R)) and its constituents in healthy male volunteers 147
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease. 147
Studies on European eel skin sulfated glycosaminoglycans: Recovery, structural characterization and anticoagulant activity 147
Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site 146
Human milk glycosaminoglycans in feces of breastfed newborns: preliminary structural elucidation and possible biological role 146
Anti-zika virus and anti-usutu virus activity of human milk and its components 146
Purification and characterization of hyaluronic acid from the mollusc bivalve Mytilus galloprovincialis 145
Hyaluronan in medical practice 145
Localization and expression of CHST6 and keratan sulfate proteoglycans in the human cornea 145
Influence of charge density, sulfate group position and molecular mass on adsorption of chondroitin sulfate onto coral 144
Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All 144
Characterization of a low-sulfated chondroitin sulfate isolated from the hemolymph of the freshwater snail Planorbarius corneus. 144
Regulation of arylsulphatases: inhibition of arylsulphatase from Haliotis rufusensis by phosphoric esters and shift of optimal pH depending on temperature 144
Recenti approcci analitici per la valutazione della qualità della propoli 144
Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose gel electrophoresis and blotting on cetylpyridinium chloride-treated nitrocellulose membranes 144
Evaluation of chondroitin sulfate bioactivity in hippocampal neurones and the astrocyte cell line U373: Influence of position of sulfate groups and charge density 144
EFFECTS OF LOW-POWER 632 NM RADIATION (HENE LASER) ON A HUMAN CELL-LINE - INFLUENCE ON ADENYLNUCLEOTIDES AND CYTOSKELETAL STRUCTURES 143
Disaccharide mapping of chondroitin sulfate of different origins by high-performance capillary electrophoresis and high-performance liquid chromatography 143
Composition of urinary glycosaminoglycans in a patient with pseudoxanthoma elasticum and familial Mediterranean fever 143
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model 143
Effect of low-frequency electromagnetic pulsed field stimulation on yeast fermentation in presence of dicarboxylic and tricarboxylic acids 142
effect of low-frequency electromagnetic pulsed-field stimulation on yeast fermentation in presence of dicarboxylic and tricarboxylic acids 141
Chondroitin sulfate in normal human plasma is modified depending on the age. Its evaluation in patients with pseudoxanthoma elasticum 141
Capillary electrophoresis determination of glucosamine in nutraceutical formulations after labeling with anthranilic acid and UV detection. 141
Chondroitin Sulfate Effect On Induced Arthritis In Rats 141
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease 141
Totale 18.154
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.157
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.888 0 0 325 595 1.113 1.363 1.369 1.108 729 379 554 353
2020/20217.428 1.145 230 492 506 675 825 663 880 358 843 434 377
2021/20225.728 214 844 516 425 158 312 312 251 718 462 801 715
2022/20236.174 692 581 425 543 684 905 183 688 819 74 285 295
2023/20244.542 227 281 197 571 1.042 351 394 584 128 134 213 420
2024/2025813 518 194 101 0 0 0 0 0 0 0 0 0
Totale 44.106